MedTrace Logo

Heparin Versus Taurolidine to Bloodstream Infection Prevention Related in Central Venous Catheter in Children

NCT02515201 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2015-08-04

No results posted yet for this study

Summary

Clinical trial, that aim is evaluation of the use of taurolidine and heparin in the prevention of bloodstream infection in venous catheter in children with intestinal failure.

Conditions

  • Catheter-Related Infections

Interventions

DRUG

Taurolidine

taurolidine in central catheter lumen

DRUG

Heparin

heparin in central venous catheter lumen

Sponsors & Collaborators

  • Hospital de Clinicas de Porto Alegre

    lead OTHER

Principal Investigators

  • Maria Carolina Witkowski, MD · Hospitall de Clínicas de Porto Alegre

  • Adriano Taniguchi, MD · Hospital de Clínicas de Porto Alegre

  • Elza Mello, PhD · Hospital de Clínicas de Porto Alegre

  • Suzi Camey, PhD · Hospital de Clínicas de Porto Alegre

  • Helena Goldani, PhD · Hospital de Clínicas de Porto Alegre

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Days
Max Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2015-03-31
Completion
2016-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02515201 on ClinicalTrials.gov